TBPH

Theravance Biopharma, Inc.

A biopharmaceutical company that makes YUPELRI (revefenacin), a once-daily nebulized medicine that helps people with COPD breathe more easily, sold in the US with partner Viatris. It grew out of Theravance, Inc., founded in 1996, which split in 2014 into two public companies, with Theravance Biopharma keeping the respiratory drug pipeline. Its name blends "therapy" and "advance"—fitting for a firm built on advancing medicine.

Recent Activity

Show $

2024Q3

1 sell

Baupost Group LLCEXIT

-4.20M shares

Baupost Group LLCEXIT

-4.20M shares

2024Q2

1 sell

Baupost Group LLCTRIM

-2.39M shares(-36.3%)

Baupost Group LLCTRIM

-2.39M shares(-36.3%)

2024Q1

1 sell

Baupost Group LLCTRIM

-825.1K shares(-11.1%)

Baupost Group LLCTRIM

-825.1K shares(-11.1%)

Loading more activity...